JEAN JACQUES BIENAIME - 08 Jan 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
08 Jan 2024
Net transactions value
-$678,747
Form type
4
Filing time
11 Jan 2024, 14:40:39 UTC
Previous filing
12 Feb 2024
Next filing
12 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Small acquisition under Rule 16a-6 $4,953 +50 +0.01% $99.05 425,162 08 Jan 2024 Direct F1
transaction BMRN Common Stock Options Exercise $631,000 +10,000 +2.4% $63.10 435,162 09 Jan 2024 Direct F2
transaction BMRN Common Stock Sale $981,900 -10,000 -2.3% $98.19 425,162 09 Jan 2024 Direct F2
transaction BMRN Common Stock Options Exercise $631,000 +10,000 +2.4% $63.10 435,162 10 Jan 2024 Direct F2
transaction BMRN Common Stock Sale $963,800 -10,000 -2.3% $96.38 425,162 10 Jan 2024 Direct F2
holding BMRN Common Stock 247,333 08 Jan 2024 Shares held by Jean-Jacques Bienaime Family Trust
holding BMRN Common Stock 100 08 Jan 2024 Shares held as UTMA custodian for child 1
holding BMRN Common Stock 100 08 Jan 2024 Shares held as UTMA custodian for child 2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -10,000 -5.5% $0.000000 171,000 09 Jan 2024 Common Stock 10,000 $63.10 Direct F3
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -10,000 -5.8% $0.000000 161,000 10 Jan 2024 Common Stock 10,000 $63.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's sale of shares at a price of $98.19 on January 9, 2024. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
F2 Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.
F3 Reflects the number of options outstanding after the transactions from this specific stock option grant.